SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zim Laboratories - Quaterly Results

14 Aug 2023 Evaluate
The sales for the June 2023 quarter moved down to Rs. 670.07 millions as compared to Rs. 925.03 millions during the year-ago period.The Net Loss for the quarter ended June 2023 is Rs. -1.43 millions as compared to Net Profit of Rs. 56.42 millions of corresponding quarter ended June 2022The company reported a degrowth in operating Profit to 51.71 millions from 132.52 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 670.07 925.03 -27.56 670.07 925.03 -27.56 3965.31 3294.94 20.35
Other Income 6.32 18.73 -66.26 6.32 18.73 -66.26 64.31 45.06 42.72
PBIDT 51.71 132.52 -60.98 51.71 132.52 -60.98 576.20 424.40 35.77
Interest 17.34 13.31 30.28 17.34 13.31 30.28 55.75 83.06 -32.88
PBDT 34.37 119.21 -71.17 34.37 119.21 -71.17 520.45 341.34 52.47
Depreciation 36.60 39.51 -7.37 36.60 39.51 -7.37 161.28 148.37 8.70
PBT -2.23 79.70 -102.80 -2.23 79.70 -102.80 359.17 192.97 86.13
TAX -0.80 23.28 -103.44 -0.80 23.28 -103.44 109.09 62.84 73.60
Deferred Tax -0.80 9.95 -108.04 -0.80 9.95 -108.04 46.30 28.84 60.54
PAT -1.43 56.42 -102.53 -1.43 56.42 -102.53 250.08 130.13 92.18
Equity 487.26 162.42 200.00 487.26 162.42 200.00 487.26 162.42 200.00
PBIDTM(%) 7.72 14.33 -46.13 7.72 14.33 -46.13 14.53 12.88 12.81

Zim Laboratories Share Price

79.72 3.72 (4.89%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×